BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35663017)

  • 21. FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas.
    Szydlowski M; Kiliszek P; Sewastianik T; Jablonska E; Bialopiotrowicz E; Gorniak P; Polak A; Markowicz S; Nowak E; Grygorowicz MA; Prochorec-Sobieszek M; Szumera-Cieckiewicz A; Malenda A; Lech-Maranda E; Warzocha K; Juszczynski P
    Blood; 2016 Feb; 127(6):739-48. PubMed ID: 26585955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide analysis of FoxO1 binding in hepatic chromatin: potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis.
    Shin DJ; Joshi P; Hong SH; Mosure K; Shin DG; Osborne TF
    Nucleic Acids Res; 2012 Dec; 40(22):11499-509. PubMed ID: 23066095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin regulation of gene expression through the forkhead transcription factor Foxo1 (Fkhr) requires kinases distinct from Akt.
    Nakae J; Kitamura T; Ogawa W; Kasuga M; Accili D
    Biochemistry; 2001 Oct; 40(39):11768-76. PubMed ID: 11570877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Deletion of the FOXO1-dependent Hepatokine FGF21 Does not Alter Basal Glucose Homeostasis or Lipolysis in Mice.
    Sostre-Colón J; Gavin MJ; Santoleri D; Titchenell PM
    Endocrinology; 2022 May; 163(5):. PubMed ID: 35303074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury.
    Kamo N; Ke B; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2013 Jan; 57(1):289-98. PubMed ID: 22807038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-dependent suppression of cholesterol 7α-hydroxylase is a possible link between glucose and cholesterol metabolisms.
    Park WH; Pak YK
    Exp Mol Med; 2011 Oct; 43(10):571-9. PubMed ID: 21817852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway.
    Huang Y; Fan X; Tao R; Song Q; Wang L; Zhang H; Kong H; Huang J
    J Cell Physiol; 2018 Oct; 233(10):6693-6704. PubMed ID: 29323718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis.
    Vázquez-Borrego MC; Del Río-Moreno M; Pyatkov M; Sarmento-Cabral A; Mahmood M; Pelke N; Wnek M; Cordoba-Chacon J; Waxman DJ; Puchowicz MA; McGuinness OP; Kineman RD
    Metabolism; 2023 Jul; 144():155589. PubMed ID: 37182789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic glucokinase is activated by insulin-like growth factor-I.
    Yoshida K; Murao K; Imachi H; Cao WM; Yu X; Li J; Ahmed RA; Kitanaka N; Wong NC; Unterman TG; Magnuson MA; Ishida T
    Endocrinology; 2007 Jun; 148(6):2904-13. PubMed ID: 17317782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
    Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
    Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells.
    Liu J; Yao Y; Huang J; Sun H; Pu Y; Tian M; Zheng M; He H; Li Z
    BMC Genomics; 2022 Jun; 23(1):425. PubMed ID: 35672672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.
    Sajan MP; Ivey RA; Farese RV
    Metabolism; 2015 Nov; 64(11):1454-65. PubMed ID: 26386696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of long non‑coding RNA expression profiles induced by resveratrol and metformin treatment for hepatic insulin resistance.
    Shu L; Hou X; Song G; Wang C; Ma H
    Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34581420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin regulates menin expression, cytoplasmic localization, and interaction with FOXO1.
    Wuescher L; Angevine K; Hinds T; Ramakrishnan S; Najjar SM; Mensah-Osman EJ
    Am J Physiol Endocrinol Metab; 2011 Sep; 301(3):E474-83. PubMed ID: 21693693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell.
    Martinez SC; Cras-Méneur C; Bernal-Mizrachi E; Permutt MA
    Diabetes; 2006 Jun; 55(6):1581-91. PubMed ID: 16731820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The FoxO1-ATGL axis alters milk lipolysis homeostasis through PI3K/AKT signaling pathway in dairy goat mammary epithelial cells.
    He Q; Gao L; Zhang F; Yao W; Wu J; Song N; Luo J; Zhang Y
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 37638641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling.
    Hu J; Shan Y; Ma J; Pan Y; Zhou H; Jiang L; Jia L
    Int J Cancer; 2019 Jul; 145(2):450-460. PubMed ID: 30613961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner.
    Choi D; Oh KJ; Han HS; Yoon YS; Jung CY; Kim ST; Koo SH
    Hepatology; 2012 Oct; 56(4):1546-56. PubMed ID: 22532369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.
    Titchenell PM; Chu Q; Monks BR; Birnbaum MJ
    Nat Commun; 2015 May; 6():7078. PubMed ID: 25963408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
    Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
    J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.